Company page
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a public biotechnology company traded under the ticker CAPR on the American stock market. The company focuses on developing innovative therapies for cardiovascular diseases and other serious conditions. With a market capitalization of approximately $1.14 billion, Capricor is positioned in the healthcare sector, aiming to advance its clinical programs and bring new treatments to patients.

- Ticker
- CAPR:NASDAQ
- Asset type
- Stock
- Market cap
- $557.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD